102
Participants
Start Date
September 14, 2022
Primary Completion Date
August 30, 2025
Study Completion Date
August 30, 2027
XIENCE Skypoint Large Vessel Everolimus Eluting Coronary Stent System (EECSS)
XIENCE Skypoint Large Vessel EECSS is composed of a L-605 CoCr stent and coated with poly (n-butyl methacrylate) (PBMA) primer and a drug coating formulation of polymer of vinylidene fluoride and hexafluoropropylene (PVDF-HFP)/everolimus pre-mounted on a balloon catheter delivery system.
Lenox Hill Hospital, New York
Pinnacle Health System, Wormleysburg
Anmed Health, Anderson
Clinique Pasteur Toulouse, Toulouse
Memorial Hospital Jacksonville, Jacksonville
Tallahassee Research Institute, Tallahassee
Via Christi Regional Medical Center - St. Francis Campus, Wichita
Bryan Heart, Lincoln
Arkansas Heart Hospital, Little Rock
The Heart Hospital Baylor Plano, Plano
Shannon Clinic, San Angelo
Austin Heart, Austin
Hendrick Medical Center, Abilene
Greenville Health System, Greenville
Hopital Cardiovasculaire et Pneumologique Louis Pradel, Lyon
Hospital Clinico San Carlos, Madrid
Hospital Universitario Marqués de Valdecilla, Santander
Hospital Virgen de Rocio, Seville
Lead Sponsor
Abbott Medical Devices
INDUSTRY